Aarti Pharmalabs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aarti Pharmalabs has informed the stock exchanges that its trading window will be closed from Wednesday, April 1, 2026, until 48 hours after the declaration of its financial results for the quarter and full financial year ending March 31, 2026. This is a routine compliance measure under SEBI's Insider Trading Regulations, 2015, to prevent insiders from trading while in possession of unpublished financial data. The company has also notified all designated persons and connected persons of this restriction. The date of the board meeting to approve the Q4 and FY26 results will be communicated separately.
This is a standard regulatory filing and has no direct impact on shareholders. Investors should note that the Q4 and FY26 earnings announcement is expected shortly after April 1, 2026, which could be a catalyst for stock movement.